117 related articles for article (PubMed ID: 35766210)
1. One-year experience with virtual multidisciplinary neuro-oncology tumor board during the COVID-19 pandemic.
Varela S; Vidrine DW; Marquez J; Kazim SF; Kogan M; Ormsby JW; Schroeder TM; Santacruz KS; Botros JA; Spader HS; Schmidt MH; Bowers CA
J Neurosurg Sci; 2022 Dec; 66(6):589-591. PubMed ID: 35766210
[No Abstract] [Full Text] [Related]
2. COVID-19 Board: Our Multidisciplinary Cutaneous Oncology Tumor Board During the Coronavirus-19 Pandemic.
Chow M; Jiang SIB
Dermatol Surg; 2020 Sep; 46(9):1224-1225. PubMed ID: 32740206
[No Abstract] [Full Text] [Related]
3. Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience.
Dharmarajan H; Anderson JL; Kim S; Sridharan S; Duvvuri U; Ferris RL; Solari MG; Clump DA; Skinner HD; Ohr JP; Zandberg DP; Branstetter B; Hughes MA; Traylor KS; Seethala R; Chiosea SI; Nilsen ML; Johnson JT; Kubik MW
Head Neck; 2020 Jun; 42(6):1310-1316. PubMed ID: 32329958
[TBL] [Abstract][Full Text] [Related]
4. Impact of Covid-19 pandemic on neuro-oncology multidisciplinary tumor board in the pre-vaccine era: the Normandy experience.
Lacaud M; Leclerc A; Marguet F; Faisant M; Lesueur P; El Ouazzani H; Di Fiore F; Hanzen C; Emery E; Langlois O; Fontanilles M
Neurochirurgie; 2023 May; 69(3):101429. PubMed ID: 36870566
[TBL] [Abstract][Full Text] [Related]
5. Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.
Schäfer N; Bumes E; Eberle F; Fox V; Gessler F; Giordano FA; Konczalla J; Onken J; Ottenhausen M; Scherer M; Schneider M; Vatter H; Herrlinger U; Schuss P
J Neurooncol; 2021 Jul; 153(3):479-485. PubMed ID: 34115248
[TBL] [Abstract][Full Text] [Related]
6. ISNO Position Statement on Treatment Guidance in Neuro-oncology During Pandemics.
Gupta T; Singh VP; Balasubramian A; Menon H; Kurkure PA; Kumar S; Jalali R
Neurol India; 2020; 68(4):769-773. PubMed ID: 32859812
[TBL] [Abstract][Full Text] [Related]
7. Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic.
Lichter KE; Drew T; Demeulenaere S; Wong E; Mohamad O; Yom SS; Bagshaw HP
JAMA Oncol; 2022 Sep; 8(9):1351-1352. PubMed ID: 35737362
[TBL] [Abstract][Full Text] [Related]
8. Burnout in medical oncology during the COVID-19 pandemic.
Franceschi E; Brandes AA
Expert Rev Anticancer Ther; 2021 Apr; 21(4):351-353. PubMed ID: 33353446
[No Abstract] [Full Text] [Related]
9. The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic.
Bitar N; Kattan J; Kourie HR; Mukherji D; Saghir NE
Future Oncol; 2020 Apr; 16(11):615-617. PubMed ID: 32266838
[No Abstract] [Full Text] [Related]
10. The ethics of neuro-oncology in the era of COVID-19: lessons to be learned.
Das S
Neuro Oncol; 2020 Sep; 22(9):1399. PubMed ID: 32470110
[No Abstract] [Full Text] [Related]
11. Tele-neuro-oncology: Current Practices and Future Directions.
Wasilewski A; Mohile N
Curr Oncol Rep; 2022 Jan; 24(1):99-103. PubMed ID: 35059995
[TBL] [Abstract][Full Text] [Related]
12. Psychooncological care for patients with cancer during 12 months of the Covid-19 pandemic: Views and experiences of senior psychooncologists at German Comprehensive Cancer Centers.
Dinkel A; Goerling U; Hönig K; Karger A; Maatouk I; Petermann-Meyer A; Senf B; Woellert K; Wünsch A; Zimmermann T; Schulz-Kindermann F
Psychooncology; 2021 Nov; 30(11):1982-1985. PubMed ID: 34184361
[TBL] [Abstract][Full Text] [Related]
13. The provision of neuro-oncology and glioma neurosurgery during the SARS-CoV-2 pandemic: a single national tertiary centre experience.
Amoo M; Horan J; Gilmartin B; Nolan D; Corr P; MacNally S; Husien MB; Javadpour M
Ir J Med Sci; 2021 Aug; 190(3):905-911. PubMed ID: 33155104
[TBL] [Abstract][Full Text] [Related]
14. [COVID-19 impact on the cancer care structuration: Example of the multidisciplinary team meeting dedicated to oncology in Occitanie].
Grosclaude P; Azria D; Guimbaud R; Thibault S; Daubisse-Marliac L; Cartron G; Renaudie MJ; Dalbies PA; Delord JP; Bauvin E
Bull Cancer; 2020; 107(7-8):730-737. PubMed ID: 32425210
[TBL] [Abstract][Full Text] [Related]
15. [Organisation of cancer care during the COVID-19 pandemic : experience from CHU Liège].
Jérusalem G
Rev Med Liege; 2020 Sup; 75(S1):38-40. PubMed ID: 33211420
[TBL] [Abstract][Full Text] [Related]
16. Multi-Level Governance of COVID-19 Pandemic and the Solitude Within Geriatric Oncology.
Fonseca VL; Caeiro JC; Juliao RM
Front Public Health; 2021; 9():647444. PubMed ID: 33996726
[No Abstract] [Full Text] [Related]
17. Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies.
Deng J; Lukens JN; Cohn JC; McMenamin E; Murphy B; Spinelli BA; Murphy N; Steinmetz AK; Landriau MA; Lin A
Trials; 2022 Nov; 23(1):927. PubMed ID: 36348346
[TBL] [Abstract][Full Text] [Related]
18. Dramatic Changes in Oncology Care Pathways During the COVID-19 Pandemic: The French ONCOCARE-COV Study.
Brugel M; Carlier C; Essner C; Debreuve-Theresette A; Beck MF; Merrouche Y; Bouché O
Oncologist; 2021 Feb; 26(2):e338-e341. PubMed ID: 33111460
[TBL] [Abstract][Full Text] [Related]
19. The effect of COVID-19 pandemic on daily oncology clinical practice.
Codacci-Pisanelli G; Giuliani J; Bonetti A
Crit Rev Oncol Hematol; 2021 Nov; 167():103272. PubMed ID: 33647444
[No Abstract] [Full Text] [Related]
20. Oncology Practice During the COVID-19 Pandemic.
Schrag D; Hershman DL; Basch E
JAMA; 2020 May; 323(20):2005-2006. PubMed ID: 32282023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
